{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:25:53Z","timestamp":1774362353556,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/24105-3"],"award-info":[{"award-number":["2012\/24105-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["443816\/2014-0"],"award-info":[{"award-number":["443816\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejps.2020.105295","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T19:17:42Z","timestamp":1583435862000},"page":"105295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-9053","authenticated-orcid":false,"given":"Thais","family":"Arag\u00e3o Horoiwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael Pretto","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Migotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Let\u00edcia","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia N.P.","family":"Cerize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano M.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105295_bib0001","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2019.07.110","article-title":"Copper nanoparticles promote rapid wound healing in acute full thickness defect via acceleration of skin cell migration, proliferation, and neovascularization","volume":"517","author":"Alizadeh","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2020.105295_bib0002","unstructured":"Brasil, 2017. Guia de vigil\u00e2ncia em sa\u00fade [WWW Document]. URLhttps:\/\/www.hc.ufu.br\/sites\/default\/files\/tmp\/\/volume_3_guia_de_vigilancia_em_saude_2017.pdf(accessed 11.20.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2018.06.020","article-title":"Use of iontophoresis for the treatment of cancer","volume":"284","author":"Byrne","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105295_bib0005","series-title":"Estudo de sistemas nanocarreadores para o \u00e1cido 5-aminolevul\u00ednico com aplica\u00e7\u00e3o na terapia fotodin\u00e2mica","author":"Cerize","year":"2012"},{"key":"10.1016\/j.ejps.2020.105295_bib0003","unstructured":"Brazilian Health Surveillance Agency, 2010. Antimoniate meglumine [WWW document]. Brazilian pharmacopoeia - 5th Edition. 648. URL http:\/\/portal.anvisa.gov.br\/documents\/33832\/2845829\/FBrasileira+Volume+2+INGLES+com+alerta_reduzido.pdf\/ae1f3f03-cb05-4bdd-883e-8d644cf644aa (accessed 8.28.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0006","unstructured":"Cerize, N.N.P., Oliveira, A.M.de, R\u00e9, M.I., Tedesco, A.C., 2013. Colloidal nanoscale carriers for active hydrophilic substances and method for producing same. US20130197100 A1."},{"issue":"12","key":"10.1016\/j.ejps.2020.105295_bib60","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.jinorgbio.2005.08.015","article-title":"Complexation of antimony (SbV) with guanosine 5\u2019-monophosphate and guanosine 5\u2019-diphospho-D-mannose: formation of both mono- and bis-adducts","volume":"99","author":"Chai","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejps.2020.105295_bib0007","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0006-291X(90)91959-V","article-title":"Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis","volume":"166","author":"Chakraborty","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2020.105295_bib0008","unstructured":"Colombia, 2010. Gu\u00eda para la Atenci\u00f3n Cl\u00ednica Integral del Paciente con Leishmaniasis [WWW document]. URLhttps:\/\/www.minsalud.gov.co\/Documents\/Salud.P\u00fablica\/Ola.invernal\/Clinica.Leishmaniasis.pdf(accessed 8.28.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0009","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2011.04.014","article-title":"Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200","volume":"9","author":"Cortez","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejps.2020.105295_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejps.2020.105295_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1009200330741","article-title":"Physico-chemical characterization of meglumine antimoniate","volume":"12","author":"Demicheli","year":"1999","journal-title":"BioMetals"},{"key":"10.1016\/j.ejps.2020.105295_bib0012","first-page":"1","article-title":"Application of chitosan and its derivatives in nanocarrier based pulmonary drug delivery systems","volume":"5","author":"Dua","year":"2017","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.ejps.2020.105295_bib0013","article-title":"Skin permeation of hydrophobic drugs loaded into polymeric nanoparticles","author":"Feitosa","year":"2016","journal-title":"TechConnect Briefs"},{"key":"10.1016\/j.ejps.2020.105295_bib0014","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2020.105295_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.569763","article-title":"The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers","volume":"28","author":"Grabnar","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2020.105295_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S1984-82502012000100002","article-title":"Polymeric micelles and molecular modeling applied to the development of radiopharmaceuticals","volume":"48","author":"Grallert","year":"2012","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105295_bib0017","first-page":"74","article-title":"Development of polymeric colloidal nanocarrier based on maltodextrin","volume":"1","author":"Horoiwa","year":"2017","journal-title":"Rev. IPT"},{"key":"10.1016\/j.ejps.2020.105295_bib0018","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5373-mr-2018-0074","article-title":"Process evaluation of sugar-based polymeric colloidal nanocarrier formation","volume":"22","author":"Horoiwa","year":"2019","journal-title":"Mater. Res."},{"key":"10.1016\/j.ejps.2020.105295_bib0019","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1016\/j.biomaterials.2012.02.033","article-title":"A review of glycosylated carriers for drug delivery","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2020.105295_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2007.01.016","article-title":"Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials","volume":"57","author":"Khatami","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2020.105295_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym10101133","article-title":"Hyaluronic acid-based nanomaterials for cancer therapy","volume":"10","author":"Kim","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ejps.2020.105295_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2013.03.021","article-title":"Novel iontophoretic administration method for local therapy of breast cancer","volume":"168","author":"Komuro","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105295_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/10611861003622552","article-title":"Cyclodextrins for drug delivery","volume":"18","author":"Laza-Knoerr","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2020.105295_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1201-9712(03)90002-6","article-title":"Therapy of cutaneous leishmaniasis","volume":"7","author":"Lee","year":"2003","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejps.2020.105295_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10847-009-9554-5","article-title":"Inclusion complex of usnic acid with \u03b2-cyclodextrin: characterization and nanoencapsulation into liposomes","volume":"64","author":"Lira","year":"2009","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ejps.2020.105295_bib0026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2006.06.014","article-title":"Mode of action of \u03b2-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate","volume":"325","author":"Martins","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105295_bib0027","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.ejps.2020.105295_bib0028","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2020.105295_bib0029","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/08982104.2012.762519","article-title":"Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis","volume":"23","author":"Momeni","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejps.2020.105295_bib0030","unstructured":"Momentive, 2016. SF1540: Technical Data Sheet, HCD-14402."},{"key":"10.1016\/j.ejps.2020.105295_bib0031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exppara.2014.04.013","article-title":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice","volume":"143","author":"Moosavian Kalat","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejps.2020.105295_bib0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2019.03.004","article-title":"The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB\/c mice","volume":"200","author":"Moosavian","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejps.2020.105295_bib0033","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2020.105295_bib0034","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.1225152","article-title":"Compartmentalized control of skin immunity by resident commensals","volume":"337","author":"Naik","year":"2012","journal-title":"Science (80-.)"},{"key":"10.1016\/j.ejps.2020.105295_bib0035","series-title":"Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications","first-page":"531","article-title":"Responsive polysaccharides and polysaccharides-based nanoparticles for drug delivery","author":"Ngwuluka","year":"2018"},{"key":"10.1016\/j.ejps.2020.105295_bib0036","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"Nyl\u00e9n","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejps.2020.105295_bib0037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejps.2020.105295_bib0038","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/ma12162540","article-title":"Antimicrobial silver nanoparticles for wound healing application: progress and future trends","volume":"12","author":"Paladini","year":"2019","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ejps.2020.105295_bib0039","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MJT.0b013e3181822e90","article-title":"Current treatment for cutaneous leishmaniasis: a review","volume":"16","author":"Palumbo","year":"2009","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ejps.2020.105295_bib0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijpharm.2013.07.035","article-title":"Strategies for the design of orally bioavailable antileishmanial treatments","volume":"454","author":"Pham","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105295_bib0041","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Pinto Reis","year":"2006","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2020.105295_bib0042","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jmmm.2008.02.050","article-title":"In vitro studies of cutaneous retention of magnetic nanoemulsion loaded with zinc phthalocyanine for synergic use in skin cancer treatment","volume":"320","author":"Primo","year":"2008","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.ejps.2020.105295_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the Middle East: incidence and epidemiology","volume":"8","author":"Salam","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2020.105295_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.126207","article-title":"TLR9\/MyD88\/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection","volume":"4","author":"Sauter","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejps.2020.105295_bib0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1590\/S0100-879X2005001200017","article-title":"Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate","volume":"38","author":"Schettini","year":"2005","journal-title":"Brazilian J. Med. Biol. Res."},{"key":"10.1016\/j.ejps.2020.105295_bib0046","first-page":"161","article-title":"Iontophoresis in drug delivery: basic principles and applications","volume":"11","author":"Singh","year":"1994","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2020.105295_bib0047","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cis.2006.11.023","article-title":"Silicone emulsions","volume":"128\u2013130","author":"Somasundaran","year":"2006","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2020.105295_bib0048","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1773-2247(14)50140-2","article-title":"In vitro release, skin permeation and retention of benzophenone-3 from microemulsions (o\/w and w\/o)","volume":"24","author":"Songkro","year":"2014","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2020.105295_bib0049","unstructured":"The United States Pharmacopeial Convention, 2016. 1724 Semisolid drug products \u2013 performance tests (No. USP39)."},{"key":"10.1016\/j.ejps.2020.105295_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpb.2008.09.026","article-title":"Multifunctional and stimuli-sensitive pharmaceutical nanocarriers","volume":"71","author":"Torchilin","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105295_bib0051","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijantimicag.2011.05.012","article-title":"Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages","volume":"38","author":"Treiger Borborema","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2020.105295_bib0052","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1381612023396230","article-title":"Cell biology of Leishmania spp.: invading and evading","volume":"8","author":"Vannier-Santos","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2020.105295_bib0053","unstructured":"WHO, 2017. Peru: Leishmaniasis country profile - 2015[WWW Document]. URLhttps:\/\/www.who.int\/leishmaniasis\/burden\/Peru_2015-hl3.pdf?ua=1(accessed 8.28.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0054","unstructured":"WHO, 2016. Leishmaniasis [WWW Document]. URLhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs375\/en\/(accessed 4.28.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0055","unstructured":"WHO, 2016. Mexico: Leishmaniasis cutaneous and mucosal 2016 [WWW document]. URLhttp:\/\/www.panaftosa.org\/leish\/inf2016_en\/INFO_MEX_ENGLISH_2016.pdf(accessed 12.1.17)."},{"key":"10.1016\/j.ejps.2020.105295_bib0056","unstructured":"WHO, 2010. First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases [WWW document]. URLhttps:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44440\/9789241564090_eng.pdf;jsessionid=BBBF9E30A8418792342BB6B439C3CF5D?sequence=1(accessed 8.28.19)."},{"key":"10.1016\/j.ejps.2020.105295_bib0057","unstructured":"WHO, Sanofi, 2011. WHO - Sanofi Collaborative report 2006-2011: a partnership to save lives."},{"key":"10.1016\/j.ejps.2020.105295_bib0058","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11095-009-9998-8","article-title":"Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy","volume":"27","author":"Wu","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105295_bib0059","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jconrel.2015.09.053","article-title":"Designing polymers with sugar-based advantages for bioactive delivery applications","volume":"219","author":"Zhang","year":"2015","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:51:11Z","timestamp":1760529071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720300841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":60,"alternative-id":["S0928098720300841"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105295","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105295"}}